Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study
Influenza and Other Respiratory Viruses · 2024
DOI: 10.1111/irv.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Takeshi Arashiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vaccines Medical, Sanofi, Tokyo, Japan. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Influenza, Human, Hospitalization, Databases, Factual. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi, AstraZeneca.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) and influenza virus are major viral etiologies of pediatric lower respiratory tract infection, but comparative data on inpatient burden are lacking.
Methods
Using a large‐scale health claims database in Japan, we identified patients under 5 years of age with a confirmed RSV or influenza diagnosis as an outpatient or inpatient between 2011 and 2022. Hospitalization rate, inpatient characteristics, various in‐hospital outcomes/complications, and healthcare resource utilization were described.
Results
A total of 176,911 RSV‐confirmed outpatients, 153,383 influenza‐confirmed outpatients, 90,413 RSV‐confirmed hospitalizations, and 11,186 influenza‐confirmed hospitalizations were identified. Among outpatients, 24.7% of RSV infection and 2.8% of influenza cases required hospitalization within 1 week. There was no co‐morbidities/prematurity for 95.0% of RSV hospitalizations and 96.5% of influenza hospitalizations. Proportions of in‐hospital outcomes/complications were (RSV infection vs. influenza): oxygen use 47.6% vs. 14.8%, mechanical ventilation 2.1% vs. 0.7%, pneumonia 33.6% vs. 12.8%, otitis media 7.7% vs. 2.3%, febrile seizure 1.5% vs. 34.4%, encephalitis/encephalopathy 0.1% vs. 0.5%, myocarditis < 0.1% vs. 0.6%, antibiotics prescription 48.0% vs. 24.4%. The mean inpatient stay was 6.1 vs. 4.3 days at direct medical costs of 435,744 vs. 315,809 JPY/patient. These trends held true in age‐stratified data. In‐hospital death occurred in 31 RSV infection and 6 influenza cases.
Conclusions
Although both infections resulted in substantial burden, RSV infection led to more frequent hospitalizations, worse in‐hospital outcomes, longer inpatient stays, higher medical costs, and more frequent antibiotics prescription compared to influenza. Most RSV hospitalizations occurred among healthy term children, emphasizing the need for prevention measures in all children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vaccines Medical, Sanofi, Tokyo, Japan.
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
- School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
- Vaccines Medical, Sanofi, Lyon, France.
- Vaccines Medical, Sanofi, Beijing, China.
- Real World Evidence, Syneos Health, Beijing, China.
ORCID-Profile: Takeshi Arashiro
Förderung
- Sanofi
- AstraZeneca
Zitieren
APA
Arashiro, T., Kramer, R., Jin, J., Kano, M., Wang, F., & Miyairi, I. (2024). Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70045
Vancouver
Arashiro T, Kramer R, Jin J, Kano M, Wang F, Miyairi I. Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70045
BibTeX
@article{Arashiro2024,
author = {Arashiro, Takeshi and Kramer, Rolf and Jin, Jing and Kano, Munehide and Wang, Fangyuan and Miyairi, Isao},
title = {Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
doi = {10.1111/irv.70045}
}
EUVIMED